Wolverine Blend combines synthetic BPC-157 with TB500 and is designed for laboratory research on cellular migration, cytoskeletal dynamics, and angiogenic signaling pathways. This dual-peptide formulation has...
Wolverine Blend combines synthetic BPC-157 with TB500 and is designed for laboratory research on cellular migration, cytoskeletal dynamics, and angiogenic signaling pathways. This dual-peptide formulation has been investigated in preclinical models to elucidate potential complementary mechanisms in fibroblast proliferation (BPC-157 via FAK/paxillin) and actin sequestration (TB500 via G-actin binding), thereby supporting studies of tissue remodeling under controlled experimental conditions.
Every compound is manufactured to research-grade standards and intended strictly for laboratory and research use. Consistent quality you can build a reproducible protocol around.
Batch number on every vial
Published Certificates of Analysis
Purity verified by third-party testing
Temperature-sensitive compounds are stored and shipped under controlled conditions, so material arrives in the state your research requires. Expert support on hand at every step.
Wolverine Blend - BPC-157 (10mg) / TB500 (10mg) is a combination of two synthetic peptides: BPC-157, a 15–amino acid fragment, and TB500, a longer peptide derived from thymosin beta-4. Together, they form a multi-component system designed for research into cellular signaling and tissue-related processes.
This peptide combination has been studied for its potential interaction with pathways involved in cellular migration, angiogenesis, and structural repair. Provided in a research-grade vial format, Wolverine Blend is used in controlled laboratory environments to explore synergistic peptide activity and biological regulation.
For laboratory research use only.
This peptide blend is being researched for its potential role in tissue repair, angiogenesis, and cellular regeneration. BPC-157 has been studied for its involvement in cellular migration and structural repair processes, while TB500 has been investigated for its role in actin regulation and tissue remodeling.
Combined, these peptides are being explored for their potential synergistic effects on biological systems involved in healing and cellular communication. Research is ongoing in in-vitro and preclinical models to better understand how peptide combinations may influence complex cellular environments.
In experimental studies, BPC-157 and TB500 have been evaluated individually and in combination across various laboratory models. Concentrations typically range from microgram to milligram levels, depending on the experimental design, with assessments focused on cellular proliferation, migration, and protein expression.
Observed findings suggest that the combination may influence processes related to cytoskeletal organization and tissue repair signaling. However, these findings are limited to preclinical and in-vitro research and should not be interpreted as established outcomes. No standardized dosing protocols exist for human use.
Compliance Notice: This product is intended for laboratory research use only and is not approved for human or veterinary use. It is not intended for diagnostic, therapeutic, or clinical applications. Any reference to biological activity or potential effects is based solely on preclinical or in-vitro findings and should not be interpreted as validated clinical outcomes. Researchers are responsible for ensuring proper handling, storage, and disposal in accordance with institutional, federal, and international guidelines.
Subscribe for exclusive offers and updates on new arrivals